Human neutralising antibodies elicited by SARS‐CoV‐2 non‐D614G variants offer cross‐protection against the SARS‐CoV‐2 D614G variant

OBJECTIVES: The emergence of a SARS‐CoV‐2 variant with a point mutation in the spike (S) protein, D614G, has taken precedence over the original Wuhan isolate by May 2020. With an increased infection and transmission rate, it is imperative to determine whether antibodies induced against the D614 isol...

詳細記述

保存先:
書誌詳細
出版年:Clin Transl Immunology
主要な著者: Lee, Cheryl Yi‐Pin, Amrun, Siti Naqiah, Chee, Rhonda Sin‐Ling, Goh, Yun Shan, Mak, Tze‐Minn, Octavia, Sophie, Yeo, Nicholas Kim‐Wah, Chang, Zi Wei, Tay, Matthew Zirui, Torres‐Ruesta, Anthony, Carissimo, Guillaume, Poh, Chek Meng, Fong, Siew‐Wai, Bei, Wang, Lee, Sandy, Young, Barnaby Edward, Tan, Seow‐Yen, Leo, Yee‐Sin, Lye, David C, Lin, Raymond TP, Maurer‐Stroh, Sebastien, Lee, Bernett, Wang, Cheng‐I, Renia, Laurent, Ng, Lisa FP
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2021
主題:
Short Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7899292/
https://ncbi.nlm.nih.gov/pubmed/33628442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1241
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料